↓ Skip to main content

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype

Overview of attention for article published in BMC Cancer, October 2010
Altmetric Badge

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype
Published in
BMC Cancer, October 2010
DOI 10.1186/1471-2407-10-568
Pubmed ID
Authors

Junichi Kurebayashi, Naoki Kanomata, Takuya Moriya, Yuji Kozuka, Mika Watanabe, Hiroshi Sonoo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 30%
Student > Master 3 13%
Student > Bachelor 2 9%
Professor > Associate Professor 2 9%
Researcher 2 9%
Other 4 17%
Unknown 3 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 26%
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Medicine and Dentistry 4 17%
Biochemistry, Genetics and Molecular Biology 2 9%
Chemical Engineering 1 4%
Other 2 9%
Unknown 4 17%